Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Baumgartner, C.
Right arrow Articles by Baumgartner, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumgartner, C.
Right arrow Articles by Baumgartner, D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
*Genetics Home Reference
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Biomarker Discovery, Disease Classification, and Similarity Query Processing on High-Throughput MS/MS Data of Inborn Errors of Metabolism

Christian Baumgartner

Research Group for Clinical Bioinformatics, Institute for Biomedical Engineering, University for Health Sciences, Medical Informatics and Technology, A-6060 Hall i. T., Austria.

Daniela Baumgartner

Department of Pediatrics, Innsbruck Medical University, A-6020 Innsbruck, Austria; Research Group for Clinical Bioinformatics, Institute for Biomedical Engineering, University for Health Sciences, Medical Informatics and Technology, A-6060 Hall i. T., Austria.

In newborn errors of metabolism, biomarkers are urgently needed for disease screening, diagnosis, and monitoring of therapeutic interventions. This article describes a 2-step approach to discovermetabolic markers, which involves (1) the identification ofmarker candidates and (2) the prioritization of thembased on expert knowledge of diseasemetabolism. For step 1, the authors developed a new algorithm, the biomarker identifier (BMI), to identifymarkers fromquantified diseased versus normal tandemmass spectrometry data sets. BMI produces a ranked list ofmarker candidates and discards irrelevant metabolites based on a quality measure, taking into account the discriminatory performance, discriminatory space, and variance ofmetabolites’ concentrations at the state of disease. To determine the ability of identified markers to classify subjects, the authors compared the discriminatory performance of several machine-learning paradigms and described a retrieval technique that searches and classifies abnormal metabolic profiles from a screening database. Seven inborn errors of metabolism— phenylketonuria (PKU), glutaric acidemia type I (GA-I), 3-methylcrotonylglycinemia deficiency (3-MCCD), methylmalonic acidemia (MMA), propionic acidemia (PA), medium-chain acylCoAdehydrogenase deficiency (MCADD), and 3-OH longchain acyl CoA dehydrogenase deficiency (LCHADD)—were investigated. All primarily prioritized marker candidates could be confirmed by literature. Somenovel secondary candidateswere identified (i.e., C16:1 andC4DCfor PKU, C4DCfor GA-I, and C18:1 forMCADD), which require further validation to confirmtheir biochemical role during health and disease.

Key Words: biomarker discovery • disease classification • similarity query processing • tandemmass spectrometry • metabolic disorders

References

  • Chace DH, DiPerna JC, NaylorEW: Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millennium. Acta Paediatr (Suppl)1999;88:45-47.[CrossRef][Medline] [Order article via Infotrieve]
  • CharrowJ, Goodman SI, McCabeER, Rinaldo P: Tandemmass spectrometry in newborn screening. Genet Med2000;2:267-269.
  • Gamache PH, Meyer DF, Granger MC, Acworth IN: Metabolomic applications of electrochemistry/mass spectrometry. J Am Soc Mass Spectrom 2004;15:1717-1726.[Medline] [Order article via Infotrieve]
  • DunnWB, Bailey NJ, Johnson HE: Measuring the metabolome: current analytical technologies. Analyst2005;130:606-625.[Medline] [Order article via Infotrieve]
  • RoschingerW, Olgemoller B, Fingerhut R, Liebl B, Roscher AA: Advances in analytical mass spectrometry to improve screening for inheritedmetabolic diseases. Eur J Pediatr2003;162(Suppl 1):S67-S76.[Medline] [Order article via Infotrieve]
  • Wilcken B, Wiley V, Hammond J, Carpenter K: Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 2003;348:2304-2312.[Abstract/Free Full Text]
  • Strauss AW: Tandem mass spectrometry in discovery of disorders of the metabolome. Clin Invest2004;113:354-356.[CrossRef]
  • Neville P, Tan PY, Mann G, Wolfinger R: Generalizable mass spectrometry mining used to identify disease state biomarkers from blood serum. Proteomics2003;3:1710-1715.[Medline] [Order article via Infotrieve]
  • Lee JW, Weiner RS, Sailstad JM, Bowsher RR, KnuthDW, O’Brien PJ, et al: Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: a conference report. Pharm Res2005;22:499-511.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gao J, Garulacan LA, Storm SM, Opiteck GJ, Dubaquie Y, Hefta SA, et al: Biomarker discovery in biological fluids. Methods2005;35:291-302.[CrossRef][Medline] [Order article via Infotrieve]
  • German JB, Bauman DE, Burrin DG, Failla ML, Freake HC, King JC, et al: Metabolomics in the opening decade of the 21st century: building the roads to individualized health. J Nutr2004;134:2729-2732.[Abstract/Free Full Text]
  • American College of Medical Genetics/American Society of Human Genetics Test and Technology Transfer Committee Working Group: Tandem mass spectrometry in newborn screening. Genet Med2000;2:267-269.[Medline] [Order article via Infotrieve]
  • Blau N, Thony B, Cotton RGH, Hyland K: Disorders of tetrahydrobiopterin and related biogenic amines. In Scriver CR, Kaufman S, Eisensmith E, Woo SLC, Vogelstein B, ChildsB(eds): TheMetabolic andMolecularBases of Inherited Disease. 8th ed. New York: McGraw-Hill, 2001.
  • Donlon J, Levy H, Scriver CR: Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In Scriver CR, Beaudet AL, Sly SW, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease [Online]. New York: McGraw-Hill, 2004.
  • Hoffmann GF, Zschocke J: Glutaric aciduria type I: from clinical, biochemical and molecular diversity to successful therapy. J Inherit Metab Dis 1999;22:381-391.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Clayton PT, Doig M, Ghafari S, Meaney C, Taylor C, Leonard JV, et al: Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry. Arch Dis Child 1998;79:109-115.[Abstract/Free Full Text]
  • Dezateux C: Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome. Eur J Pediatr2003;162(Suppl 1):S25-S28.[Medline] [Order article via Infotrieve]
  • Rinaldo P, Matern D, Bennett MJ: Fatty acid oxidation disorders. Annu Rev Physiol2002;64:477-502.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Duda RO, Hart PE, Stork GG: Pattern Classification. NewYork: JohnWiley, 2001.
  • Hosmer DW, Lemeshow S: Applied Logistic Regression. 2nd ed. New York: JohnWiley, 2000.
  • Baumgartner C, Böhm C, Baumgartner D, Marini G, Weinberger K, Olgemöller B, et al: Supervised machine learning techniques for the classification of metabolic disorders in newborns. Bioinformatics2004;20:2985-2996.[Abstract/Free Full Text]
  • Hall MA, Holmes G: Benchmarking attribute selection techniques for discrete class data mining. IEEE Trans Knowledge Data Eng2003;15:1437-1447.[CrossRef]
  • Purohit PV, RockeDM: Discriminant models for high-throughput proteomics mass spectrometer data. Proteomics2003;3:1699-1703.[Medline] [Order article via Infotrieve]
  • Vlahou A, Schorge JO, GregoryBW, ColemanRL: Diagnosis of ovarian cancer using decision tree classification of mass spectral data. J Biomed Biotechnol2003;5:308-314.
  • Ball G, Mian S, Holding F, Allibone RO, Lowe J, Ali S, et al: An integrated approach utilizing artificial neural networks and seldi mass spectrometry for the classification of human tumors and rapid identification of potential biomarkers. Bioinformatics2002;18:395-404.[Abstract/Free Full Text]
  • Baumgartner C, Böhm C, Baumgartner D: Modelling of classification rules on metabolic patterns including machine learning and expert knowledge. J Biomed Inform2005;38:89-98.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mitchell TM: Machine Learning. Boston: McGraw-Hill, 1997.
  • Cristianini N, Shawe-Taylor J: An Introduction to Support Vector Machines and Other Kernel-Based Learning Methods. Cambridge, UK: Cambridge University Press, 2000.
  • Shawe-Taylor J, Cristianini N: Kernel Methods for Pattern Analysis. Cambridge, UK: Cambridge University Press, 2004.
  • Gelman A, Carlin JB, Stern HS, Rubin DB: Bayesian Data Analysis2nd ed. London: Chapman & Hall/CRC Press, 2004.
  • Raudys S: Statistical andNeuralClassifiers. London: Springer-Verlag, 2001.
  • Witten IH, Frank E: Data Mining: Practical Machine Learning Tools and Techniques with Java Implementations. San Francisco: Morgan Kaufmann, 2000.
  • LilienRH, FaridH, Donald BR: Probabilistic disease classification of expression-dependent proteomic data from mass spectrometry of human serum. J Comput Biol2003;10:925-946.[CrossRef][Medline] [Order article via Infotrieve]
  • Baggerly KA, Morris JS, CoombesKR: Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics2004;20:777-785.[Abstract/Free Full Text]
  • Yu JS, Ongarello S, Fiedler R, ChenXW, ToffoloG, Cobelli C, Trajanoski Z: Ovarian cancer identification based on dimensionality reduction for highthroughput mass spectrometry data. Bioinformatics2005;21:2200-2209.[Abstract/Free Full Text]
  • Thomason MJ, Lord J, BainMD, Chalmers RA, Littlejohns P, Addison GM, et al: A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism. J Public Health Med 1998;20:331-343.[Abstract/Free Full Text]
  • Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S: Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandemmass spectrometry: a systematic review. Health Technol Assess 2004;8:iii,1-121.[Medline] [Order article via Infotrieve]
  • Beecher C: The human metabolome. In HarriganGG, GoodacreR(eds): Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis. Berlin: Kluwer Academic, 2003.

This version was published on February 1, 2006

Journal of Biomolecular Screening, Vol. 11, No. 1, 90-99 (2006)
DOI: 10.1177/1087057105280518


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
BioinformaticsHome page
M. Netzer, G. Millonig, M. Osl, B. Pfeifer, S. Praun, J. Villinger, W. Vogel, and C. Baumgartner
A new ensemble-based algorithm for identifying breath gas marker candidates in liver disease using ion molecule reaction mass spectrometry
Bioinformatics, April 1, 2009; 25(7): 941 - 947.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Ho, Z. Lukacs, G. F. Hoffmann, M. Lindner, and T. Wetter
Feature Construction Can Improve Diagnostic Criteria for High-Dimensional Metabolic Data in Newborn Screening for Medium-Chain Acyl-CoA Dehydrogenase Deficiency
Clin. Chem., July 1, 2007; 53(7): 1330 - 1337.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Baumgartner, C.
Right arrow Articles by Baumgartner, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumgartner, C.
Right arrow Articles by Baumgartner, D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
*Genetics Home Reference
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?